CATALOGO DEI PRODOTTI DELLA RICERCA

VIAPIANA, Ombretta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.267
EU - Europa 8.633
AS - Asia 6.373
SA - Sud America 916
AF - Africa 97
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 10
Totale 25.314
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.139
GB - Regno Unito 2.833
CN - Cina 2.441
SG - Singapore 2.365
IT - Italia 1.403
DE - Germania 837
BR - Brasile 785
RU - Federazione Russa 738
HK - Hong Kong 727
SE - Svezia 691
FR - Francia 644
IE - Irlanda 593
FI - Finlandia 408
VN - Vietnam 151
KR - Corea 150
UA - Ucraina 142
IN - India 130
JP - Giappone 118
TR - Turchia 101
CA - Canada 72
NL - Olanda 62
AT - Austria 50
BE - Belgio 44
PL - Polonia 42
AR - Argentina 41
ES - Italia 34
BD - Bangladesh 33
MX - Messico 32
ID - Indonesia 29
EC - Ecuador 27
ZA - Sudafrica 23
VE - Venezuela 22
RO - Romania 21
TG - Togo 20
UZ - Uzbekistan 18
IQ - Iraq 17
IR - Iran 17
AU - Australia 14
CH - Svizzera 11
CL - Cile 11
CO - Colombia 10
EG - Egitto 10
MA - Marocco 10
PK - Pakistan 9
DZ - Algeria 8
SA - Arabia Saudita 8
AL - Albania 7
GR - Grecia 7
PY - Paraguay 7
BO - Bolivia 6
AZ - Azerbaigian 5
BG - Bulgaria 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
DK - Danimarca 5
HU - Ungheria 5
IL - Israele 5
KE - Kenya 5
NP - Nepal 5
PT - Portogallo 5
QA - Qatar 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
TH - Thailandia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
EE - Estonia 4
EU - Europa 4
HR - Croazia 4
JM - Giamaica 4
LT - Lituania 4
LV - Lettonia 4
PE - Perù 4
AM - Armenia 3
HN - Honduras 3
JO - Giordania 3
KG - Kirghizistan 3
KW - Kuwait 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BW - Botswana 2
ET - Etiopia 2
GE - Georgia 2
LB - Libano 2
LK - Sri Lanka 2
ME - Montenegro 2
MK - Macedonia 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
PH - Filippine 2
RS - Serbia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
A1 - Anonimo 1
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
Totale 25.283
Salva come PNG Salva come JPEG
Città #
Southend 2.632
Chandler 1.335
Dallas 1.212
Singapore 1.096
Jacksonville 883
Hong Kong 723
Dublin 590
Ashburn 514
Ann Arbor 475
Woodbridge 465
Beijing 390
Houston 285
Lawrence 234
Princeton 234
Wilmington 232
Jinan 224
New York 195
Redmond 194
Bologna 187
Nanjing 173
Shenyang 172
Los Angeles 166
Verona 158
Munich 143
Helsinki 126
Hebei 104
Milan 103
Tokyo 103
Buffalo 101
Tianjin 87
Redondo Beach 85
Sindelfingen 85
The Dalles 85
Changsha 75
Zhengzhou 71
Ningbo 68
Haikou 67
São Paulo 66
Columbus 65
Taizhou 58
Nanchang 57
Redwood City 54
Santa Clara 53
Hangzhou 52
Guangzhou 48
Jiaxing 48
Seattle 46
Taiyuan 44
Turku 43
Brussels 42
Rome 41
San Francisco 40
Ho Chi Minh City 39
Hyderabad 37
Norwalk 35
Washington 35
Boardman 34
Warsaw 33
Vienna 32
Brooklyn 31
Moscow 30
Fuzhou 29
Toronto 28
Düsseldorf 27
Fairfield 27
Lanzhou 26
Dong Ket 25
Brasília 23
Falls Church 23
Rio de Janeiro 23
Chicago 22
Dearborn 22
Hanoi 22
Torino 22
Jakarta 21
Lancaster 21
London 21
Lomé 20
Boston 19
Detroit 18
Seoul 18
Mexico City 17
Naples 17
Tashkent 17
Atlanta 16
Belo Horizonte 16
Nürnberg 16
Sanayi 16
Venice 16
Dongguan 15
Orani 15
Phoenix 15
Porto Alegre 15
Turin 15
Campinas 14
Charlotte 14
Padova 14
Amsterdam 13
Cagliari 13
Chennai 13
Totale 15.879
Salva come PNG Salva come JPEG
Nome #
Efficacia dei bisfosfonati nella terapia della spondilite anchilosante: confronto con infliximab 626
Teriparatide and denosumab combination therapy and skeletal metabolism 267
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 200
Artrite Reumatoide e Metabolismo Minerale 200
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 187
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 186
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 179
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 169
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 169
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 157
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 153
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 149
Bone metabolism in patients with anorexia nervosa and amenorrhoea 148
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 147
Anti-CCP antibodies and bone 147
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 145
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 143
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 141
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 141
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 141
[Risk factors for hip fracture in elderly persons]. 141
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 139
Prevalence and incidence of rheumatoid arthritis in Italy. 138
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 137
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 137
DXA bone mineral density in males: retrospective study in real life. 136
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 136
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 136
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 135
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 135
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 135
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 133
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 132
Guidelines for the diagnosis, prevention and management of osteoporosis 132
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 130
Bone involvement and osteoporosis in mastocytosis. 129
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 128
[Pathophysiology of osteoarthritis: perspectives] 127
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 127
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 127
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 125
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 122
Safety issues and adverse reactions with osteoporosis management 121
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 121
Could γ\δ T-cells explain zoledronic acid adverse events? 121
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 121
Allergy and the bone: unexpected relationships 120
Prevalence of osteoporosis in patients affected by mastocytosis 120
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 120
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 120
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 119
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 119
Osteopetrosi 118
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 118
Is it possible to use the identification of neutrophil gelatinase- associated lipocalin (NGAL) in the evaluation of bisphosphonates nephrotoxicity? [E' possibile utilizzare la determinazione della lipocalina associata alla gelatinasi dei neutrofili (NGAL) nella valutazione della nefrotossicità da bisfosfonati?] 117
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 117
Drug-induced osteonecrosis of the jaw: the state of the art 116
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 116
Bone turnover markers in patients with osteogenesis imperfecta. 115
Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study 115
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 115
Bone turnover markers in patients with osteogenesis imperfecta 114
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 114
Sclerostin and DKK1 in primary hyperparathyroidism. 114
Effects of denosumab on peripheral lymphocyte subpopulations 113
Bone Disease in Mastocytosis 112
Artropatie degenerative 111
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 111
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 111
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 110
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 110
Duration of treatment for osteoporosis 110
Focal bone involvement in inflammatory arthritis: the role of IL17 109
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 108
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 108
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 107
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 107
Malnutrition and sarcopenia in a large cohort of patients with systemic sclerosis 107
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 105
IBANDRONATE: NEW OPTIONS IN THE TREATMENT OF OSTEOPOROSIS 105
Intravenous bisphosphonate therapy increases radial width in adults with Osteogenesis Imperfecta. 105
Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid Arthritis 105
The Association between Weight Gain/Restoration and Bone Mineral Density in Adolescents with Anorexia Nervosa: A Systematic Review 105
The obesity paradox and osteoporosis 105
Strong relationship between vitamin D status and bone mineral density in anorexia nervosa 105
Osteoporosi 104
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. 104
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 104
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros 104
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 104
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study 104
Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study 104
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 104
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 104
Vitamin D and rheumatic diseases. 103
Effects of antiangiogenetic drugs on microcirculation and macrocirculation in patients with advanced-stage renal cancer 103
Ruolo della vitamina D 102
Osteoporosi ed attività sportiva: 102
Variazione della densità minerale ossea ed attività antifratturativa; 102
Long-term consequences of a treatment course with bisphosphonates in primary hyperparathyroidism 101
Totale 13.121
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.376
article - articoli 96.107
book - libri 0
conference - conferenze 514
curatela - curatele 0
other - altro 1.133
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.622
Totale 200.752
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.466 0 0 0 300 306 207 74 96 165 15 202 101
2021/20221.908 127 520 29 110 88 55 59 107 145 48 143 477
2022/20234.026 282 380 382 709 332 966 51 224 461 59 129 51
2023/20242.170 111 163 193 264 238 344 103 171 28 92 318 145
2024/20255.346 286 344 259 800 248 166 220 210 789 419 529 1.076
2025/20263.576 1.202 888 1.302 184 0 0 0 0 0 0 0 0
Totale 25.828